Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Pre Market
Current status date:
2021-07-15
Original market date: See footnote 1
Product name:
GENERESS
DIN:
02435659
Product Monograph/Veterinary Labelling:
Date:
2020-01-31
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ALLERGAN INC
300
1380 Rodick Road
Markham
Ontario
Canada
L3R 4G5
Class:
Human
Dosage form(s):
Tablet (Chewable)
Route(s) of administration:
Oral
Number of active ingredient(s):
2
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
68:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
G03AA05 NORETHISTERONE AND ESTROGEN
Active ingredient group (AIG) number:See footnote5
0210010003
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| ETHINYL ESTRADIOL | 0.025 MG |
| NORETHINDRONE | 0.8 MG |